Business Context and Reporting Period
Company: Inmune Bio, Inc. (INMB)
Filing Type: Form 8-K (Current Report)
Date of Report: March 4, 2025
Event: Regulation FD Disclosure regarding the furnishing of an Investor Presentation (Exhibit 99.1).
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the availability of an investor presentation deck and does not contain audited or unaudited financial statements.
Material Changes
No material financial changes or operational updates are detailed within the text of this filing. The document references the creation of a slide deck for future presentations but does not disclose the specific content or data points contained therein.
Guidance, Outlook, and Risks
Management Commentary: The Company has prepared a slide deck intended for use in presentations from time to time.
Legal Status of Information: The information in Item 7.01 and Exhibit 99.1 is furnished and shall not be deemed "filed" under Section 18 of the Exchange Act. It is not subject to the liabilities of that section and shall not be incorporated by reference into any other filings under the Securities Act or Exchange Act.
Risks: No specific risks or contingencies are enumerated in this filing text.
Investor Verification Checklist
- Review Exhibit 99.1 (Investor Presentation) separately to obtain the actual financial data and strategic outlook referenced in this filing.
- Verify that the presentation materials are not incorporated by reference into other SEC filings, as explicitly stated in the report.
- Confirm the trading status of Common Stock (Symbol: INMB) on The NASDAQ Stock Market LLC.